Literature DB >> 3621844

Giant cell arteritis precipitated by a diagnostic trial of prednisolone in suspected polymyalgia rheumatica.

P A Reilly, P J Maddison.   

Abstract

A 62-year-old woman developed symptoms of polymyalgia rheumatica (PMR), but without clinical evidence of concomitant giant cell arteritis (GCA). A single blind, placebo-controlled trial of prednisolone confirmed the diagnosis, but in addition unwittingly exposed clinically silent giant cell arteritis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3621844     DOI: 10.1007/bf02201034

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  7 in total

1.  Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings.

Authors:  P Fauchald; O Rygvold; B Oystese
Journal:  Ann Intern Med       Date:  1972-12       Impact factor: 25.391

2.  Polymyalgia rheumatica in general practice. A report of five cases.

Authors:  J T Cope
Journal:  J R Coll Gen Pract       Date:  1969-10

3.  Polymyalgia rheumatica. Abrupt and gradual withdrawal of prednisolone treatment, clinical and laboratory observations.

Authors:  W Esselinckx; S M Doherty; A S Dixon
Journal:  Ann Rheum Dis       Date:  1977-06       Impact factor: 19.103

4.  Peripheral joint involvement in polymyalgia rheumatica: a clinical study of 56 cases.

Authors:  A S Al-Hussaini; A J Swannell
Journal:  Br J Rheumatol       Date:  1985-02

5.  The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome.

Authors:  M E Ellis; S Ralston
Journal:  Ann Rheum Dis       Date:  1983-04       Impact factor: 19.103

6.  Development of giant cell (temporal) arteritis in a patient 'adequately' treated for polymyalgia rheumatica.

Authors:  R I Rynes; P Mika; L E Bartholomew
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

7.  Prognosis and management of polymyalgia rheumatica.

Authors:  J G Jones; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1981-02       Impact factor: 19.103

  7 in total
  1 in total

1.  Treatment of polymyalgia rheumatica and giant cell arteritis.

Authors:  M T Watts; M E Nelson; I G Rennie
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.